1. New biosensor for breast cancer biomarkers HER2 & CA15-3 in saliva.
2. Limit of detection is 1 femtogram/ml.
3. Sensitivity is significantly better than ELISA methods.
4. Enables real-time results for noninvasive screening.
5. Study cohort included healthy participants and breast cancer patients.
6. Combines results for high diagnostic accuracy.
7. Potential for mobile health applications in rural areas.
8. Further validation in larger populations needed.

Source: biosensors